BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 6507052)

  • 21. Estradiol and progesterone receptors in breast cancer: prognostic value after relapse.
    Bonneterre J; Horner D; Peyrat JP; Vandewalle B; Cambier L; Demaille A
    Breast Cancer Res Treat; 1985; 5(2):149-54. PubMed ID: 4016280
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ethnic variation in estrogen and progesterone receptor concentration in leiomyoma and normal myometrium.
    Sadan O; van Iddekinge B; Savage N; Robinson M; Zakut H
    Gynecol Endocrinol; 1988 Dec; 2(4):275-82. PubMed ID: 3232551
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correlation between estradiol-17 beta and progesterone cytosol receptor concentration, histologic differentiation and 3H-thymidine incorporation in endometrial carcinoma.
    Lindahl B; Alm P; Borg A; Fernö M; Grundsell H; Johnsson JE; Norgren A; Tropé C
    Anticancer Res; 1982; 2(4):203-7. PubMed ID: 7149649
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytoplasmic estrogen and progesterone receptor content of uterine sarcomas.
    Soper JT; McCarty KS; Hinshaw W; Creasman WT; McCarty KS; Clarke-Pearson DL
    Am J Obstet Gynecol; 1984 Oct; 150(4):342-8. PubMed ID: 6486200
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Steroid hormone receptors in struma].
    Stoss F; Spona J
    Wien Klin Wochenschr; 1987 Jun; 99(13):460-1. PubMed ID: 3630175
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endocrine aspects of human uterine sarcoma: a preliminary study.
    Tseng L; Tseng JK; Mann WJ; Chumas JC; Stone ML; Mazella J; Sun B; Amalfitano TG; Wallach RC
    Am J Obstet Gynecol; 1986 Jul; 155(1):95-101. PubMed ID: 2942037
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hormonal receptors in endometrial neoplasias.
    Contreras Ortiz O; Sananes CE
    Eur J Gynaecol Oncol; 1988; 9(5):396-8. PubMed ID: 2975993
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Simultaneous estradiol and progesterone receptor analysis in meningiomas.
    Lesch KP; Fahlbusch R
    Surg Neurol; 1986 Sep; 26(3):257-63. PubMed ID: 3738720
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Fundamentals and clinical significance of steroid hormone receptors, 17 beta-hydroxysteroid-dehydrogenase and serum tumor markers in endometrial carcinoma].
    Pollow K; Kreienberg R
    Gynakologe; 1983 Jun; 16(2):93-8. PubMed ID: 6576967
    [No Abstract]   [Full Text] [Related]  

  • 30. [Specific receptors for sex hormones in tumors of the central nervous system].
    de Campos Gutiérrez JM; Ramos Duce F; Gómez Lopez PA; Kusak Lambea ME; Boixadós Servat JR
    Rev Esp Oncol; 1984; 31(2):289-97. PubMed ID: 6545709
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The clinical value of hormone receptor assays in malignant disease.
    Friedman MA; Hoffman PG; Jones HW
    Cancer Treat Rev; 1978 Dec; 5(4):185-94. PubMed ID: 216491
    [No Abstract]   [Full Text] [Related]  

  • 32. [Relationship between histopathological type and biochemical dosage of estradiol and progesterone receptors in women with primary carcinoma of the breast].
    Gebrim LH; de Lima GR; dos Santos HB; Guidugli Neto J; Grabert H
    Rev Paul Med; 1987; 105(4):195-200. PubMed ID: 3454477
    [No Abstract]   [Full Text] [Related]  

  • 33. [Presence of hormone receptors in gastric cancers. 3 cases].
    Delaitre B; Zimmer R; Leandri R; Louvel A; Chapuis Y
    Presse Med; 1984 Jun; 13(26):1631. PubMed ID: 6330721
    [No Abstract]   [Full Text] [Related]  

  • 34. Correlation of estrogen and progesterone receptors with histologic differentiation in endometrial adenocarcinoma.
    McCarty KS; Barton TK; Fetter BF; Creasman WT; McCarty KS
    Am J Pathol; 1979 Jul; 96(1):171-83. PubMed ID: 464018
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Leiomyomas: steroid receptor content. Variation within normal menstrual cycles.
    Soules MR; McCarty KS
    Am J Obstet Gynecol; 1982 May; 143(1):6-11. PubMed ID: 7081313
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Progesterone Receptor Expression Is an Independent Prognosticator in FIGO Stage I Uterine Leiomyosarcoma.
    Davidson B; Kjæreng ML; Førsund M; Danielsen HE; Kristensen GB; Abeler VM
    Am J Clin Pathol; 2016 Apr; 145(4):449-58. PubMed ID: 27149024
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytoplasmic steroid receptors in tumoral and "normal" endometrial samples from symmetrical uterine zones.
    Enriori CL; Vico CM; Calandra RS; Charreau EH
    Gynecol Oncol; 1989 Apr; 33(1):40-3. PubMed ID: 2703165
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Breast neoplasms: possible prognostic role of steroid receptors].
    Barbi GP; Marroni P; Zappa R; Bruzzi P; Nicolò G; Toma S; Paganuzzi M; Ferrara GB
    Minerva Ginecol; 1987 Apr; 39(4):225-8. PubMed ID: 3601195
    [No Abstract]   [Full Text] [Related]  

  • 39. [Determination of estradiol and progesterone receptors in breast cancer. Determination by Scatchard's method or by a single point test].
    Peyrat JP; Fournier J
    Bull Cancer; 1987; 74(6):647-8. PubMed ID: 3435790
    [No Abstract]   [Full Text] [Related]  

  • 40. Decreased ratio of total progesterone to total estradiol receptor levels in endometria of women with adult dysfunctional uterine bleeding.
    Gorodeski IG; Geier A; Siegal A; Beery R; Lunenfeld B; Langzam J; Bahari CM
    Gynecol Obstet Invest; 1986; 22(1):22-8. PubMed ID: 3744125
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.